Cargando…
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo
Recent studies suggest a positive correlation between glycogen synthase kinase-3 (GSK-3) activation and tumor growth. Currently, it is unclear how both Akt that inhibits GSK-3 and active GSK-3 are maintained concurrently in tumor cells. We investigated the role of GSK-3 and the existence of an Akt-r...
Autores principales: | Goc, Anna, Al-Husein, Belal, Katsanevas, Katerina, Steinbach, Alison, Lou, Uvette, Sabbineni, Harika, DeRemer, David L., Somanath, Payaningal R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996673/ https://www.ncbi.nlm.nih.gov/pubmed/24519956 |
Ejemplares similares
-
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis
por: Goc, Anna, et al.
Publicado: (2012) -
Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
por: Gao, Fei, et al.
Publicado: (2015) -
Rac1 Activation Driven by 14-3-3ζ Dimerization Promotes Prostate Cancer Cell-Matrix Interactions, Motility and Transendothelial Migration
por: Goc, Anna, et al.
Publicado: (2012) -
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011) -
Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer
por: Somanath, Payaningal R., et al.
Publicado: (2023)